Wolverine Trading
TCRT icon

Wolverine Trading’s Alaunos Therapeutics TCRT Stock Holding History

Wolverine Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-158
Closed -$6.81K – 5100
2023
Q2 		$11.7K Buy
158
+15
+10% +$1.21K ﹤0.01% 4133
2023
Q1 		$14K Sell
143
-15
-9% -$1.43K ﹤0.01% 4047
2022
Q4 		$15K Sell
158
-162
-51% -$23.5K ﹤0.01% 3783
2022
Q3 		$95K Sell
320
-60
-16% -$17.4K ﹤0.01% 3937
2022
Q2 		$71K Buy
380
+270
+245% +$25.8K ﹤0.01% 3955
2022
Q1 		$11K Buy
+110
New +$14.1K ﹤0.01% 5293
2021
Q3 		– Sell
-112
Closed -$45K – 6938
2021
Q2 		$45K Buy
112
+22
+24% +$10.3K ﹤0.01% 5615
2021
Q1 		$46K Sell
90
-144
-62% -$89.7K ﹤0.01% 5662
2020
Q4 		$93K Buy
+234
New +$93K ﹤0.01% 4484
2020
Q3 		– Sell
-86
Closed -$38K – 5125
2020
Q2 		$42K Sell
86
-23
-21% -$10.3K ﹤0.01% 4340
2020
Q1 		$42K Sell
109
-394
-78% -$204K ﹤0.01% 4307
2019
Q4 		$362K Buy
503
+120
+31% +$82.6K ﹤0.01% 3378
2019
Q3 		$242K Sell
383
-254
-40% -$201K ﹤0.01% 3382
2019
Q2 		$557K Buy
637
+152
+31% +$105K ﹤0.01% 2609
2019
Q1 		$280K Sell
485
-112
-19% -$46.8K ﹤0.01% 3443
2018
Q4 		$149K Buy
+597
New +$236K ﹤0.01% 3831
2018
Q3 		– Sell
-183
Closed -$108K – 5855
2018
Q2 		$108K Hold
183
– – ﹤0.01% 4697
2018
Q1 		$108K Sell
183
-134
-42% -$83.5K ﹤0.01% 4697
2017
Q4 		$197K Buy
317
+213
+205% +$153K ﹤0.01% 4171
2017
Q3 		$96K Buy
+104
New +$92.4K ﹤0.01% 4079
2017
Q2 		– Sell
-167
Closed -$161K – 4946
2017
Q1 		$161K Buy
+167
New +$156K ﹤0.01% 3654
2016
Q4 		– Sell
-193
Closed -$174K – 5129
2016
Q3 		$161K Sell
193
-311
-62% -$250K ﹤0.01% 3955
2016
Q2 		$436K Buy
+504
New +$549K ﹤0.01% 2357

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Wolverine Trading's TCRT Position: Q3 2023 in Review

Wolverine Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2023, closing a stake of 158 shares — an estimated $6.81K sold.

Wolverine Trading first reported a position in TCRT in Q2 2016 and held it in 23 quarters. The position peaked at $557K in Q2 2019. 89 funds tracked by Wall St. Rank hold TCRT as of Q3 2023.

  • Wolverine Trading reported no remaining Alaunos Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Wolverine Trading sold 158 Alaunos Therapeutics shares in Q3 2023, an estimated $6.81K.
  • Wolverine Trading first reported a position in Alaunos Therapeutics in Q2 2016 and held it in 23 quarters.
  • Wolverine Trading's Alaunos Therapeutics position peaked at $557K in Q2 2019.
  • 89 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.